Trial
NCT02508311
Albuterol to Improve Respiratory Strength in SCI
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
Spinal Cord Injury
Intervention
Oral Albuterol Extended Release
Why stopped
Our ability to test subjects with tetraplegia in this interventional study was interrupted by the COVID-19 pandemic. Our research pharmacist also informed us that oral albuterol is no longer being manufactured.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-07